Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis

有氧运动对前列腺癌预后基因组特征的影响

基本信息

  • 批准号:
    9243994
  • 负责人:
  • 金额:
    $ 62.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-14 至 2020-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Prostate cancer is the most commonly diagnosed cancer among men in the United States with more than 241,000 new diagnoses in 2012. Nearly half of the men diagnosed have early stage, low-grade disease, and may be good candidates for active surveillance (AS). AS is an important management option because it reduces overtreatment, including the serious side effects (e.g., incontinence, erectile dysfunction) of standard prostate cancer therapies. However, AS is under-utilized because current clinical tests are imperfect at discerning indolent from aggressive prostate cancer. Furthermore, approximately 15% of men who initially opt for AS ultimately seek curative treatment in the absence of biological progression, due to the anxiety and stress of knowing they have cancer. Hence, identifying strategies that reduce risk of prostate cancer progression and allay AS-specific anxiety could greatly reduce the overtreatment of low risk prostate cancer and benefit public health. We reported that vigorous physical activity and brisk walking after prostate cancer diagnosis were associated with ~60% reductions in prostate cancer progression or death in two distinct cohorts of men with prostate cancer. While compelling, these studies do not address if increasing aerobic exercise after diagnosis favorably alters prostate cancer biology. Our group and others have identified and validated novel prostate genomic signatures that predict poor clinical outcomes among men with low risk prostate cancer, and demonstrated that gene expression in the prostate is modified by short-term lifestyle interventions. Thus, we propose to conduct a randomized controlled trial to evaluate whether 24 weeks of supervised aerobic exercise vs. usual care affects the expression of three validated prostate genomic signatures among 120 men with prostate cancer on AS at the University of California, San Francisco and Duke University. Men assigned to the exercise arm will participate in an individually tailored treadmill-walking program that includes five 30- 45 minute sessions per week at 50-80% of baseline cardiorespiratory fitness (three supervised, two at home). We will also examine the global effects of aerobic exercise on mRNA expression of cancer-related pathways in tumor and normal tissue (e.g. growth factor signaling, angiogenesis, DNA repair); and whether aerobic exercise reduces AS-related anxiety and overall stress compared to usual care. The AS protocol of regular prostate biopsies provides a unique opportunity to study the longitudinal effects of aerobic exercise on prostate cancer biology. The results of this randomized controlled trial will provide the essential evidence needed to support a definitive phase III clinical trial o exercise and prostate cancer progression.
描述(由申请人提供):前列腺癌是美国男性中最常诊断的癌症,2012年有超过241,000例新诊断。近一半的男性诊断为早期,低度疾病,可能是积极监测(AS)的良好候选人。AS是一种重要的管理选择,因为它减少了过度治疗,包括严重的副作用(例如,尿失禁、勃起功能障碍)的标准前列腺癌治疗。然而,AS是利用不足,因为目前的临床试验是不完善的区分惰性从侵略性前列腺癌。此外,大约15%最初选择AS的男性最终在没有生物学进展的情况下寻求治愈性治疗,这是由于知道他们患有癌症的焦虑和压力。因此,确定降低前列腺癌进展风险和减轻AS特异性焦虑的策略可以大大减少低风险前列腺癌的过度治疗,并有益于公众健康。我们报告了在两个不同的前列腺癌男性队列中,前列腺癌诊断后进行剧烈的体力活动和快走与前列腺癌进展或死亡减少约60%相关。虽然令人信服,但这些研究并没有解决诊断后增加有氧运动是否会有利地改变前列腺癌生物学。我们的研究小组和其他人已经确定并验证了新的前列腺基因组特征,这些特征预测了低风险前列腺癌男性的不良临床结局,并证明了前列腺中的基因表达通过短期生活方式干预而改变。因此,我们建议进行一项随机对照试验,以评估24周的监督有氧运动与常规护理是否会影响加州大学弗朗西斯科分校和杜克大学的120名患有前列腺癌的AS男性中三个经验证的前列腺基因组签名的表达。分配到运动臂的男性将参加一个单独定制的跑步机步行计划,包括每周五次30- 45分钟的训练,心肺功能为基线的50-80%(三次监督,两次在家)。我们还将研究有氧运动对肿瘤和正常组织中癌症相关通路(例如生长因子信号传导,血管生成,DNA修复)的mRNA表达的整体影响;以及有氧运动是否与常规护理相比减少AS相关的焦虑和整体压力。定期前列腺活检的AS协议提供了一个独特的机会来研究有氧运动对前列腺癌生物学的纵向影响。这项随机对照试验的结果将提供必要的证据,以支持一项关于运动和前列腺癌进展的确定性III期临床试验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JUNE ML CHAN其他文献

JUNE ML CHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JUNE ML CHAN', 18)}}的其他基金

Short Courses on the Conduct of Reproducible Aging Research with Big Data
利用大数据进行可重复衰老研究的短期课程
  • 批准号:
    10501970
  • 财政年份:
    2022
  • 资助金额:
    $ 62.78万
  • 项目类别:
Short Courses on the Conduct of Reproducible Aging Research with Big Data
利用大数据进行可重复衰老研究的短期课程
  • 批准号:
    10681414
  • 财政年份:
    2022
  • 资助金额:
    $ 62.78万
  • 项目类别:
Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis
有氧运动对前列腺癌预后基因组特征的影响
  • 批准号:
    8615849
  • 财政年份:
    2014
  • 资助金额:
    $ 62.78万
  • 项目类别:
Prostate Microenvironmental & Prostate Cancer Progression
前列腺微环境
  • 批准号:
    7282354
  • 财政年份:
    2006
  • 资助金额:
    $ 62.78万
  • 项目类别:
Prostate Microenvironmental & Prostate Cancer Progression
前列腺微环境
  • 批准号:
    7048051
  • 财政年份:
    2006
  • 资助金额:
    $ 62.78万
  • 项目类别:
Prostate Microenvironmental & Prostate Cancer Progression
前列腺微环境
  • 批准号:
    7485604
  • 财政年份:
    2006
  • 资助金额:
    $ 62.78万
  • 项目类别:
Prostate Microenvironmental & Prostate Cancer Progression
前列腺微环境
  • 批准号:
    7666279
  • 财政年份:
    2006
  • 资助金额:
    $ 62.78万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 62.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 62.78万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 62.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 62.78万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 62.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 62.78万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 62.78万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 62.78万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 62.78万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 62.78万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了